John T. Vetto

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

Medicine, Immunology, Oncology +15

Engagement of the OX-40 Receptor In Vivo Enhances Antitumor Immunity

Andrew D. Weinberg, Martin-Muy Rivera, Rodney A. Prell et al. · The Journal of Immunology · 2000 · 386 citations · Full text

Life Sciences, Immunology, Oncology +17

Clinical effects and toxicity of interleukin-2 in patients with cancer

Michael T. Lotze, Yvedt L. Matory, Anthony A. Rayner et al. · Cancer · 1986 · 358 citations · Full text

Life Sciences, Immunology, Oncology +13

Perioperative Blood Transfusions are Associated with Decreased Time to Recurrence and Decreased Survival after Resection of Colorectal Liver Metastases

Keith Stephenson, Seth M. Steinberg, Kevin S. Hughes et al. · Annals of Surgery · 1988 · 244 citations

Medicine, Oncology, Surgery +17

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

Dale Han, Jonathan S. Zager, Yu Shyr et al. · Journal of Clinical Oncology · 2013 · 223 citations

Medicine, Oncology, Surgery +17